Global Cancer Vaccine Market - Industry Size, Share, Trends and Forecast 2019 - 2026

Published - Jan 2019 | Category - Pharma & Healthcare | No. of Pages - 117 | Published By - Ameco Research


The global cancer vaccine market is analyzed to grow at a CAGR of around 17% during the forecast and reach the market value around USD 16 billion in 2026.

Cancer is one of the main reasons of death over the globe, with 8.8 million unfortunate casualties in 2015, and representing about 1 out of 6 deaths. The illness has seen noteworthy development over the last few decades and is relied upon to develop quickly amid the figure time frame.

Market Dynamics

The worldwide market is driven by ascend in pervasiveness of HPV infections and related cancer, increment in organization of prophylactic disease antibodies, surge in speculations and discoveries in the improvement of cancer vaccines, and launch of novel disease immunizations in the market. On the other hand, longer time required for assembling a solitary vaccine restrain the improvement of new antibodies; in this manner, hampering the market development. Moreover, high financial contributions for the advancement of malignant growth immunizations decline their appropriation in the market; in this way, hampering the market development.  


Quick Buy

Latest Publications